This report aims to provide a comprehensive presentation of the global market for Vaccine Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Conjugate. This report contains market size and forecasts of Vaccine Conjugate in global, including the following market information:
Global Vaccine Conjugate Market Revenue, 2018-2023, 2024-2029, $ millions
Global Vaccine Conjugate Market Sales, 2018-2023, 2024-2029, K Doses
Global top five Vaccine Conjugate companies in 2022 %
The global Vaccine Conjugate market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hib Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Vaccine Conjugate include Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal Wuxi Bio-Pharmaceutical, Bharat Biotech and Zhifei Biologic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC MMG has surveyed the Vaccine Conjugate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine Conjugate Market, by Type, 2018-2023, 2024-2029 $ Millions & K Doses
Global Vaccine Conjugate Market Segment Percentages, by Type, 2022 %
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Global Vaccine Conjugate Market, by Application, 2018-2023, 2024-2029 $ Millions & K Doses
Global Vaccine Conjugate Market Segment Percentages, by Application, 2022 %
Children
Adult
Global Vaccine Conjugate Market, By Region and Country, 2018-2023, 2024-2029 $ Millions & K Doses
Global Vaccine Conjugate Market Segment Percentages, By Region and Country, 2022 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccine Conjugate revenues in global market, 2018-2023 Estimated, $ millions
Key companies Vaccine Conjugate revenues share in global market, 2022 %
Key companies Vaccine Conjugate sales in global market, 2018-2023 Estimated, K Doses
Key companies Vaccine Conjugate sales share in global market, 2022 %
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal Wuxi Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccine Conjugate, market overview.
Chapter 2: Global Vaccine Conjugate market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccine Conjugate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Conjugate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccine Conjugate capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Vaccine Conjugate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Conjugate Overall Market Size
2.1 Global Vaccine Conjugate Market Size: 2022 VS 2029
2.2 Global Vaccine Conjugate Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vaccine Conjugate Sales: 2018-2029
3 Company Landscape
3.1 Top Vaccine Conjugate Players in Global Market
3.2 Top Global Vaccine Conjugate Companies Ranked by Revenue
3.3 Global Vaccine Conjugate Revenue by Companies
3.4 Global Vaccine Conjugate Sales by Companies
3.5 Global Vaccine Conjugate Price by Manufacturer 2018-2023
3.6 Top 3 and Top 5 Vaccine Conjugate Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccine Conjugate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine Conjugate Players in Global Market
3.8.1 List of Global Tier 1 Vaccine Conjugate Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vaccine Conjugate Market Size Markets, 2022 & 2029
4.1.2 Hib Vaccine
4.1.3 Meningococcal Vaccine
4.1.4 Pneumococcal Vaccine
4.1.5 Others
4.2 By Type - Global Vaccine Conjugate Revenue & Forecasts
4.2.1 By Type - Global Vaccine Conjugate Revenue, 2018-2023
4.2.2 By Type - Global Vaccine Conjugate Revenue, 2024-2029
4.2.3 By Type - Global Vaccine Conjugate Revenue Market Share, 2018-2029
4.3 By Type - Global Vaccine Conjugate Sales & Forecasts
4.3.1 By Type - Global Vaccine Conjugate Sales, 2018-2023
4.3.2 By Type - Global Vaccine Conjugate Sales, 2024-2029
4.3.3 By Type - Global Vaccine Conjugate Sales Market Share, 2018-2029
4.4 By Type - Global Vaccine Conjugate Price Manufacturers Selling Prices, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccine Conjugate Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Vaccine Conjugate Revenue & Forecasts
5.2.1 By Application - Global Vaccine Conjugate Revenue, 2018-2023
5.2.2 By Application - Global Vaccine Conjugate Revenue, 2024-2029
5.2.3 By Application - Global Vaccine Conjugate Revenue Market Share, 2018-2029
5.3 By Application - Global Vaccine Conjugate Sales & Forecasts
5.3.1 By Application - Global Vaccine Conjugate Sales, 2018-2023
5.3.2 By Application - Global Vaccine Conjugate Sales, 2024-2029
5.3.3 By Application - Global Vaccine Conjugate Sales Market Share, 2018-2029
5.4 By Application - Global Vaccine Conjugate Price Manufacturers Selling Prices, 2018-2029
6 Sights by Region
6.1 By Region - Global Vaccine Conjugate Market Size, 2022 & 2029
6.2 By Region - Global Vaccine Conjugate Revenue & Forecasts
6.2.1 By Region - Global Vaccine Conjugate Revenue, 2018-2023
6.2.2 By Region - Global Vaccine Conjugate Revenue, 2024-2029
6.2.3 By Region - Global Vaccine Conjugate Revenue Market Share, 2018-2029
6.3 By Region - Global Vaccine Conjugate Sales & Forecasts
6.3.1 By Region - Global Vaccine Conjugate Sales, 2018-2023
6.3.2 By Region - Global Vaccine Conjugate Sales, 2024-2029
6.3.3 By Region - Global Vaccine Conjugate Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Vaccine Conjugate Revenue, 2018-2029
6.4.2 By Country - North America Vaccine Conjugate Sales, 2018-2029
6.4.3 US Vaccine Conjugate Market Size, 2018-2029
6.4.4 Canada Vaccine Conjugate Market Size, 2018-2029
6.4.5 Mexico Vaccine Conjugate Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Vaccine Conjugate Revenue, 2018-2029
6.5.2 By Country - Europe Vaccine Conjugate Sales, 2018-2029
6.5.3 Germany Vaccine Conjugate Market Size, 2018-2029
6.5.4 France Vaccine Conjugate Market Size, 2018-2029
6.5.5 U.K. Vaccine Conjugate Market Size, 2018-2029
6.5.6 Italy Vaccine Conjugate Market Size, 2018-2029
6.5.7 Russia Vaccine Conjugate Market Size, 2018-2029
6.5.8 Nordic Countries Vaccine Conjugate Market Size, 2018-2029
6.5.9 Benelux Vaccine Conjugate Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Vaccine Conjugate Revenue, 2018-2029
6.6.2 By Region - Asia Vaccine Conjugate Sales, 2018-2029
6.6.3 China Vaccine Conjugate Market Size, 2018-2029
6.6.4 Japan Vaccine Conjugate Market Size, 2018-2029
6.6.5 South Korea Vaccine Conjugate Market Size, 2018-2029
6.6.6 Southeast Asia Vaccine Conjugate Market Size, 2018-2029
6.6.7 India Vaccine Conjugate Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Vaccine Conjugate Revenue, 2018-2029
6.7.2 By Country - South America Vaccine Conjugate Sales, 2018-2029
6.7.3 Brazil Vaccine Conjugate Market Size, 2018-2029
6.7.4 Argentina Vaccine Conjugate Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vaccine Conjugate Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Vaccine Conjugate Sales, 2018-2029
6.8.3 Turkey Vaccine Conjugate Market Size, 2018-2029
6.8.4 Israel Vaccine Conjugate Market Size, 2018-2029
6.8.5 Saudi Arabia Vaccine Conjugate Market Size, 2018-2029
6.8.6 UAE Vaccine Conjugate Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Vaccine Conjugate Major Product Offerings
7.1.4 Pfizer Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Vaccine Conjugate Major Product Offerings
7.2.4 GSK Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Vaccine Conjugate Major Product Offerings
7.3.4 Sanofi Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.3.5 Sanofi Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Vaccine Conjugate Major Product Offerings
7.4.4 Merck Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.4.5 Merck Key News & Latest Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Company Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Vaccine Conjugate Major Product Offerings
7.5.4 Walvax Biotechnology Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.5.5 Walvax Biotechnology Key News & Latest Developments
7.6 Royal Wuxi Bio-Pharmaceutical
7.6.1 Royal Wuxi Bio-Pharmaceutical Company Summary
7.6.2 Royal Wuxi Bio-Pharmaceutical Business Overview
7.6.3 Royal Wuxi Bio-Pharmaceutical Vaccine Conjugate Major Product Offerings
7.6.4 Royal Wuxi Bio-Pharmaceutical Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.6.5 Royal Wuxi Bio-Pharmaceutical Key News & Latest Developments
7.7 Bharat Biotech
7.7.1 Bharat Biotech Company Summary
7.7.2 Bharat Biotech Business Overview
7.7.3 Bharat Biotech Vaccine Conjugate Major Product Offerings
7.7.4 Bharat Biotech Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.7.5 Bharat Biotech Key News & Latest Developments
7.8 Zhifei Biologic
7.8.1 Zhifei Biologic Company Summary
7.8.2 Zhifei Biologic Business Overview
7.8.3 Zhifei Biologic Vaccine Conjugate Major Product Offerings
7.8.4 Zhifei Biologic Vaccine Conjugate Sales and Revenue in Global 2018-2023
7.8.5 Zhifei Biologic Key News & Latest Developments
8 Global Vaccine Conjugate Production Capacity, Analysis
8.1 Global Vaccine Conjugate Production Capacity, 2018-2029
8.2 Vaccine Conjugate Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine Conjugate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine Conjugate Supply Chain Analysis
10.1 Vaccine Conjugate Industry Value Chain
10.2 Vaccine Conjugate Upstream Market
10.3 Vaccine Conjugate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine Conjugate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Vaccine Conjugate in Global Market
Table 2. Top Vaccine Conjugate Players in Global Market, Ranking by Revenue 2022
Table 3. Global Vaccine Conjugate Revenue by Companies, US$, Mn, 2018-2023
Table 4. Global Vaccine Conjugate Revenue Share by Companies, 2018-2023
Table 5. Global Vaccine Conjugate Sales by Companies, K Doses, 2018-2023
Table 6. Global Vaccine Conjugate Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vaccine Conjugate Price 2018-2023 & USD/Dose
Table 8. Global Manufacturers Vaccine Conjugate Product Type
Table 9. List of Global Tier 1 Vaccine Conjugate Companies, Revenue US$, Mn in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Conjugate Companies, Revenue US$, Mn in 2022 and Market Share
Table 11. By Type ? Global Vaccine Conjugate Revenue, US$, Mn, 2022 & 2029
Table 12. By Type - Global Vaccine Conjugate Revenue US$, Mn, 2018-2023
Table 13. By Type - Global Vaccine Conjugate Revenue US$, Mn, 2024-2029
Table 14. By Type - Global Vaccine Conjugate Sales K Doses, 2018-2023
Table 15. By Type - Global Vaccine Conjugate Sales K Doses, 2024-2029
Table 16. By Application ? Global Vaccine Conjugate Revenue, US$, Mn, 2022 & 2029
Table 17. By Application - Global Vaccine Conjugate Revenue US$, Mn, 2018-2023
Table 18. By Application - Global Vaccine Conjugate Revenue US$, Mn, 2024-2029
Table 19. By Application - Global Vaccine Conjugate Sales K Doses, 2018-2023
Table 20. By Application - Global Vaccine Conjugate Sales K Doses, 2024-2029
Table 21. By Region ? Global Vaccine Conjugate Revenue, US$, Mn, 2022 VS 2029
Table 22. By Region - Global Vaccine Conjugate Revenue US$, Mn, 2018-2023
Table 23. By Region - Global Vaccine Conjugate Revenue US$, Mn, 2024-2029
Table 24. By Region - Global Vaccine Conjugate Sales K Doses, 2018-2023
Table 25. By Region - Global Vaccine Conjugate Sales K Doses, 2024-2029
Table 26. By Country - North America Vaccine Conjugate Revenue, US$, Mn, 2018-2023
Table 27. By Country - North America Vaccine Conjugate Revenue, US$, Mn, 2024-2029
Table 28. By Country - North America Vaccine Conjugate Sales, K Doses, 2018-2023
Table 29. By Country - North America Vaccine Conjugate Sales, K Doses, 2024-2029
Table 30. By Country - Europe Vaccine Conjugate Revenue, US$, Mn, 2018-2023
Table 31. By Country - Europe Vaccine Conjugate Revenue, US$, Mn, 2024-2029
Table 32. By Country - Europe Vaccine Conjugate Sales, K Doses, 2018-2023
Table 33. By Country - Europe Vaccine Conjugate Sales, K Doses, 2024-2029
Table 34. By Region - Asia Vaccine Conjugate Revenue, US$, Mn, 2018-2023
Table 35. By Region - Asia Vaccine Conjugate Revenue, US$, Mn, 2024-2029
Table 36. By Region - Asia Vaccine Conjugate Sales, K Doses, 2018-2023
Table 37. By Region - Asia Vaccine Conjugate Sales, K Doses, 2024-2029
Table 38. By Country - South America Vaccine Conjugate Revenue, US$, Mn, 2018-2023
Table 39. By Country - South America Vaccine Conjugate Revenue, US$, Mn, 2024-2029
Table 40. By Country - South America Vaccine Conjugate Sales, K Doses, 2018-2023
Table 41. By Country - South America Vaccine Conjugate Sales, K Doses, 2024-2029
Table 42. By Country - Middle East & Africa Vaccine Conjugate Revenue, US$, Mn, 2018-2023
Table 43. By Country - Middle East & Africa Vaccine Conjugate Revenue, US$, Mn, 2024-2029
Table 44. By Country - Middle East & Africa Vaccine Conjugate Sales, K Doses, 2018-2023
Table 45. By Country - Middle East & Africa Vaccine Conjugate Sales, K Doses, 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Vaccine Conjugate Product Offerings
Table 48. Pfizer Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Vaccine Conjugate Product Offerings
Table 52. GSK Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Vaccine Conjugate Product Offerings
Table 56. Sanofi Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 57. Sanofi Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Vaccine Conjugate Product Offerings
Table 60. Merck Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 61. Merck Key News & Latest Developments
Table 62. Walvax Biotechnology Company Summary
Table 63. Walvax Biotechnology Vaccine Conjugate Product Offerings
Table 64. Walvax Biotechnology Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 65. Walvax Biotechnology Key News & Latest Developments
Table 66. Royal Wuxi Bio-Pharmaceutical Company Summary
Table 67. Royal Wuxi Bio-Pharmaceutical Vaccine Conjugate Product Offerings
Table 68. Royal Wuxi Bio-Pharmaceutical Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 69. Royal Wuxi Bio-Pharmaceutical Key News & Latest Developments
Table 70. Bharat Biotech Company Summary
Table 71. Bharat Biotech Vaccine Conjugate Product Offerings
Table 72. Bharat Biotech Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 73. Bharat Biotech Key News & Latest Developments
Table 74. Zhifei Biologic Company Summary
Table 75. Zhifei Biologic Vaccine Conjugate Product Offerings
Table 76. Zhifei Biologic Vaccine Conjugate Sales K Doses, Revenue US$, Mn and Average Price USD/Dose 2018-2023
Table 77. Zhifei Biologic Key News & Latest Developments
Table 78. Vaccine Conjugate Production Capacity K Doses of Key Manufacturers in Global Market, 2021-2023 K Doses
Table 79. Global Vaccine Conjugate Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Vaccine Conjugate Production by Region, 2018-2023 K Doses
Table 81. Global Vaccine Conjugate Production by Region, 2024-2029 K Doses
Table 82. Vaccine Conjugate Market Opportunities & Trends in Global Market
Table 83. Vaccine Conjugate Market Drivers in Global Market
Table 84. Vaccine Conjugate Market Restraints in Global Market
Table 85. Vaccine Conjugate Raw Materials
Table 86. Vaccine Conjugate Raw Materials Suppliers in Global Market
Table 87. Typical Vaccine Conjugate Downstream
Table 88. Vaccine Conjugate Downstream Clients in Global Market
Table 89. Vaccine Conjugate Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vaccine Conjugate Segment by Type in 2022
Figure 2. Vaccine Conjugate Segment by Application in 2022
Figure 3. Global Vaccine Conjugate Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vaccine Conjugate Market Size: 2022 VS 2029 US$, Mn
Figure 6. Global Vaccine Conjugate Revenue, 2018-2029 US$, Mn
Figure 7. Vaccine Conjugate Sales in Global Market: 2018-2029 K Doses
Figure 8. The Top 3 and 5 Players Market Share by Vaccine Conjugate Revenue in 2022
Figure 9. By Type - Global Vaccine Conjugate Revenue, US$, Mn, 2022 & 2029
Figure 10. By Type - Global Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 11. By Type - Global Vaccine Conjugate Sales Market Share, 2018-2029
Figure 12. By Type - Global Vaccine Conjugate Price USD/Dose, 2018-2029
Figure 13. By Application - Global Vaccine Conjugate Revenue, US$, Mn, 2022 & 2029
Figure 14. By Application - Global Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 15. By Application - Global Vaccine Conjugate Sales Market Share, 2018-2029
Figure 16. By Application - Global Vaccine Conjugate Price USD/Dose, 2018-2029
Figure 17. By Region - Global Vaccine Conjugate Revenue, US$, Mn, 2022 & 2029
Figure 18. By Region - Global Vaccine Conjugate Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 20. By Region - Global Vaccine Conjugate Sales Market Share, 2018-2029
Figure 21. By Country - North America Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 22. By Country - North America Vaccine Conjugate Sales Market Share, 2018-2029
Figure 23. US Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 24. Canada Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 25. Mexico Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 26. By Country - Europe Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Vaccine Conjugate Sales Market Share, 2018-2029
Figure 28. Germany Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 29. France Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 30. U.K. Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 31. Italy Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 32. Russia Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 33. Nordic Countries Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 34. Benelux Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 35. By Region - Asia Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Vaccine Conjugate Sales Market Share, 2018-2029
Figure 37. China Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 38. Japan Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 39. South Korea Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 40. Southeast Asia Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 41. India Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 42. By Country - South America Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 43. By Country - South America Vaccine Conjugate Sales Market Share, 2018-2029
Figure 44. Brazil Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 45. Argentina Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 46. By Country - Middle East & Africa Vaccine Conjugate Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Vaccine Conjugate Sales Market Share, 2018-2029
Figure 48. Turkey Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 49. Israel Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 50. Saudi Arabia Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 51. UAE Vaccine Conjugate Revenue, US$, Mn, 2018-2029
Figure 52. Global Vaccine Conjugate Production Capacity K Doses, 2018-2029
Figure 53. The Percentage of Production Vaccine Conjugate by Region, 2022 VS 2029
Figure 54. Vaccine Conjugate Industry Value Chain
Figure 55. Marketing Channels
